Conventional perimetry, short-wavelength automated perimetry, frequency-doubling technology, and visual evoked potentials in the assessment of patients with multiple sclerosis

European Journal of Ophthalmology

Volumn 15, Issue 6, 2005, Pages 730-738

  Corallo, Guido ^a,c   Cicinelli, S ^a   Papadia, M ^a   Bandini, F ^b   Uccelli, A ^b   Calabria, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE   (Italy)

Author keywords

Frequency doubling technology; Multiple sclerosis; Short wavelength automated perimetry; Visual evoked potentials; Visual field

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; EVOKED VISUAL RESPONSE; FEMALE; FREQUENCY DOUBLING TECHNOLOGY PERIMETRY; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; MALE; MULTIPLE SCLEROSIS; NEUROPHYSIOLOGY; OPTIC NEURITIS; PERIMETER; PERIMETRY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SHORT WAVELENGTH AUTOMATED PERIMETRY; VISUAL FIELD DEFECT;

EID: 30444433121     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500612     Document Type: Article

References (27)

1. Sample PA, Weinreb RN. Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1990; 31: 1869-75.
2. Sample PA, Weinreb RN. Progressive color visual field loss in glaucoma. Invest Ophthalmol Vis Sci 1992; 33: 240-3.
3. Sample PA, Taylor JDN, Martinez G, Lusky M, Weinreb RN. Short-wavelength color visual fields in glaucoma suspects at risk. Am J Ophthalmol 1993; 115: 225-33.
4. Johnson CA, Adams AJ, Lewis RA. Automated perimetry of short-wavelength mechanism in glaucoma and ocular hypertension: preliminary findings. In: Heijl A, ed. Perimetry Update 1988/89. Amsterdam: Kugler and Ghedini Publications; 1989: 1869-75.
5. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 1993; 111: 645-50.
6. Johnson CA. The diagnostic value of short wavelength automated perimetry (SWAP). Curr Opin Ophthalmol 1996; 7: 49-53.
7. Schiller PH, Logothetis NK, Charles ER. Role of the color-opponent and broad-band channels in vision. Vision Res 1990; 5: 321-46.
8. Dacey DM. Morphology of a small bi-stratified ganglion cell type in the macaque and human retina. Vis Neurosci 1993; 10: 1081-8.
9. Dacey DM, Lee BB. The 'blue-on' opponent pathway in primate retina originates from a distinct ganglion cell type. Nature 1994; 367: 731-5.
10. Johnson CA. Diagnostic value of short-wavelength automated perimetry. Curr Opin Ophthalmol 1996; 7: 54-8.
11. Wild JM. Short wavelength automated perimetry. Acta Ophthalmol Scand 2001; 79: 546-59.
12. Johnson CA, Samuels S. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci 1997; 38: 413-25.
13. Kelly DH. Nonlinear visual responses to flickering sinusoidal gratings. J Opt Soc Am 1981; 71: 1051-5.
14. Maunsell JHR, Nealey TA, DePriest DD. Magnocellular and parvocellular contributions to responses in the middle temporal visual area (MT) of the macaque monkey. J Neurosci 1990; 10: 3323-34.
15. Cello KE, Nelson Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol 2000; 129: 314-22.
16. Burnstein Y, Ellish NJ, Magbalon M, Higginbotham EJ. Comparison of frequency doubling perimetry with Humphrey visual field analysis in a glaucoma practice. Am J Ophthalmol 2000; 129: 328-33.
17. Iester M, Mermoud A, Schnyder C. Frequency doubling technique in patients with ocular hypertension and glaucoma: correlation with Octopus perimeter indices. Ophthalmology 2000; 107: 288-94.
18. Keltner JL, Johnson CA. Short-wavelength automated perimetry in neuro-ophthalmologic disorders. Arch Ophthalmol 1995; 113: 475-81.
19. Johnson CA, Keltner JL. Short-wavelength automated perimetry (SWAP) in optic neuritis. In: Mills RP, Wall M, eds. Perimetry Update 1994/95. Amsterdam: Kugler Publications, 1995; 91-6.
20. Fujimoto N, Adachi-Usami E. Use of blue-on-yellow perimetry to demonstrate quadrantanopia in multiple sclerosis. Arch Ophthalmol 1998; 116: 828-9.
21. Fujimoto N, Adachi-Usami E. Frequency doubling perimetry in resolved optic neuritis. Invest Ophthalmol Vis Sci 2000; 41: 2558-60.
22. Wall M, Neahring RK, Woodward KR. Sensitivity and specificity of frequency doubling perimetry in neuroophthalmic disorders: a comparison with conventional automated perimetry. Invest Ophthalmol Vis Sci 2002; 43: 1277-83.
23. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
24. Kjaer M. Evoked potentials. With special reference to the diagnostic value in multiple sclerosis. Acta Neurol Scand 1983; 67: 67-89.
25. Kupersmith MJ, Nelson JI, Seiple WH, Carr RE, Weiss PA. The 20/20 eye in multiple sclerosis. Neurology 1983; 33: 1015-20.
26. Mienberg O, Flammer J, Ludin HP. Subclinical visual field defects in multiple sclerosis. Demonstration and quantification with automated perimetry, and comparison with visual evoked potentials. J Neurol 1982; 227: 125-33.
27. Berninger TA, Heider W. Electrophysiology and perimetry in acute retrobulbar neuritis. Doc Ophthalmol 1989; 71: 293-305.